GB201410695D0 - Uses of oligouronates in cancer treatment - Google Patents

Uses of oligouronates in cancer treatment

Info

Publication number
GB201410695D0
GB201410695D0 GB201410695A GB201410695A GB201410695D0 GB 201410695 D0 GB201410695 D0 GB 201410695D0 GB 201410695 A GB201410695 A GB 201410695A GB 201410695 A GB201410695 A GB 201410695A GB 201410695 D0 GB201410695 D0 GB 201410695D0
Authority
GB
United Kingdom
Prior art keywords
oligouronates
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201410695A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norwegian University of Science and Technology NTNU
Original Assignee
Norwegian University of Science and Technology NTNU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwegian University of Science and Technology NTNU filed Critical Norwegian University of Science and Technology NTNU
Priority to GB201410695A priority Critical patent/GB201410695D0/en
Publication of GB201410695D0 publication Critical patent/GB201410695D0/en
Priority to EP14820882.0A priority patent/EP3086847A1/en
Priority to AU2014372566A priority patent/AU2014372566B2/en
Priority to JP2016560044A priority patent/JP2017501221A/en
Priority to PCT/EP2014/079178 priority patent/WO2015097224A1/en
Priority to MX2016008304A priority patent/MX2016008304A/en
Priority to CA2934950A priority patent/CA2934950A1/en
Priority to US15/107,424 priority patent/US20160346313A1/en
Ceased legal-status Critical Current

Links

GB201410695A 2013-12-23 2014-06-16 Uses of oligouronates in cancer treatment Ceased GB201410695D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB201410695A GB201410695D0 (en) 2014-06-16 2014-06-16 Uses of oligouronates in cancer treatment
EP14820882.0A EP3086847A1 (en) 2013-12-23 2014-12-23 Uses of oligouronates in cancer treatment
AU2014372566A AU2014372566B2 (en) 2013-12-23 2014-12-23 Uses of oligouronates in cancer treatment
JP2016560044A JP2017501221A (en) 2013-12-23 2014-12-23 Use of oligouronates in cancer treatment
PCT/EP2014/079178 WO2015097224A1 (en) 2013-12-23 2014-12-23 Uses of oligouronates in cancer treatment
MX2016008304A MX2016008304A (en) 2013-12-23 2014-12-23 Uses of oligouronates in cancer treatment.
CA2934950A CA2934950A1 (en) 2013-12-23 2014-12-23 Uses of oligouronates in cancer treatment
US15/107,424 US20160346313A1 (en) 2013-12-23 2014-12-23 Uses of oligouronates in cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201410695A GB201410695D0 (en) 2014-06-16 2014-06-16 Uses of oligouronates in cancer treatment

Publications (1)

Publication Number Publication Date
GB201410695D0 true GB201410695D0 (en) 2014-07-30

Family

ID=51266661

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201410695A Ceased GB201410695D0 (en) 2013-12-23 2014-06-16 Uses of oligouronates in cancer treatment

Country Status (1)

Country Link
GB (1) GB201410695D0 (en)

Similar Documents

Publication Publication Date Title
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
IL250677B (en) Treatment of cancers using anti-nkg2a agents
HUE053654T2 (en) Combinations of fgfr- and cmet-inhibitors for the treatment of cancer
IL276733A (en) Use of eribulin in the treatment of cancer
HRP20190888T8 (en) Igf-1r antibody-drug-conjugate and its use for the treatment of cancer
IL248767B (en) Trimethoxyphenyl-benzimidazole compound for use in the treatment of cancer
HK1231561A1 (en) Cancer treatment
IL251903B (en) Apilimod for use in the treatment of colorectal cancer
GB201420533D0 (en) Use of Nanomaterials in treating cancer
GB201409363D0 (en) Skin cancer treatment
SG10202001388YA (en) Use of ureidomustine (bo-1055) in cancer treatment
GB201408297D0 (en) Treatment of cancer
GB201417456D0 (en) Treatment of cancer
GB201410695D0 (en) Uses of oligouronates in cancer treatment
GB201409362D0 (en) Treatment of cancer
GB201405449D0 (en) Treatment of cancer
GB201405075D0 (en) Treatment of cancer
ZA201403006B (en) Composition for use in treatment of cancer
GB201512723D0 (en) Treatment of cancer
GB201507928D0 (en) Treatment of cancer
GB201417465D0 (en) Treatment of cancers
GB201504617D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)